Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Worldwide, cancer is the second leading cause of mortality after cardiovascular diseases. Among the numerous malignant tumors in human, digestive system cancers are the primary cause of morbidity and mortality. Acetylation and deacetylation are crucially involved in cancer occurrence and development...
Guardado en:
Autores principales: | Bingyi Zhou, Deliang Liu, Yuyong Tan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bba92dba64941db88bd778c548d3f1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: Jacob King, et al.
Publicado: (2021) -
Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis
por: Tinghui Shao, et al.
Publicado: (2021) -
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
por: Tandon N, et al.
Publicado: (2016) -
Molecular cloning and subcellular localization of six HDACs and their roles in response to salt and drought stress in kenaf (Hibiscus cannabinus L.)
por: Wei,Fan, et al.
Publicado: (2019) -
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
por: Peedicayil J
Publicado: (2020)